EQS-News:  DEFENCE'S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous  DEFENCE’S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED 24.01.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.   ____________________________________________...

Related Keywords

Canada ,Toronto ,Ontario ,Vancouver ,British Columbia ,Frankfurt ,Brandenburg ,Germany ,Canadian ,Sebastien Plouffe ,Defence Therapeutics Inc ,News Service ,Distribution Services ,Defence Therapeutics ,Statement Regarding ,Corporate News ,Regulatory Announcements ,Unofficial Market ,Defence ,Herapeutics ,Nc ,Key ,Iscellaneous ,Melanoma ,Argeted ,Vaccine ,1 Reprogrammed ,Sc ,Fell ,Potency ,Validated ,Et Cest ,The ,